PE20070555A1 - Uso de valerato de estradiol en combinacion con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral - Google Patents
Uso de valerato de estradiol en combinacion con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oralInfo
- Publication number
- PE20070555A1 PE20070555A1 PE2006001241A PE2006001241A PE20070555A1 PE 20070555 A1 PE20070555 A1 PE 20070555A1 PE 2006001241 A PE2006001241 A PE 2006001241A PE 2006001241 A PE2006001241 A PE 2006001241A PE 20070555 A1 PE20070555 A1 PE 20070555A1
- Authority
- PE
- Peru
- Prior art keywords
- estradiol valerate
- dienogest
- combination
- oral
- units
- Prior art date
Links
- RSEPBGGWRJCQGY-RBRWEJTLSA-N Estradiol valerate Chemical compound C1CC2=CC(O)=CC=C2[C@@H]2[C@@H]1[C@@H]1CC[C@H](OC(=O)CCCC)[C@@]1(C)CC2 RSEPBGGWRJCQGY-RBRWEJTLSA-N 0.000 title abstract 6
- 229960004766 estradiol valerate Drugs 0.000 title abstract 6
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 title abstract 4
- 229960003309 dienogest Drugs 0.000 title abstract 4
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 229940083544 estradiol 2 mg Drugs 0.000 abstract 1
- 229940068196 placebo Drugs 0.000 abstract 1
- 239000000902 placebo Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
SE REFIERE AL USO DE VALERATO DE ESTRADIOL EN COMBINACION CON 17a-CIANOMETIL-17-ß-HIDROXIESTRA-4,9-DIEN-3-ONA (DIENOGEST) CUYA ADMINISTRACION COMPRENDE: A) UNA PRIMERA FASE DE 2 UNIDADES DE DOSIS DIARIAS DE 3MG DE VALERATO DE ESTRADIOL; B) UNA SEGUNDA FASE DE DOS GRUPOS DE UNIDADES DE DOSIS DIARIAS QUE CONTIENEN: i) 5 UNIDADES DE UNA COMBINACION DE 2MG DE VALERATO DE ESTRADIOL Y 2MG DE DIENOGEST, Y ii) 17 UNIDADES DE UNA COMBINACION DE 2MG DE VALERATO DE ESTRADIOL Y 3MG DE DIENOGEST; C) UNA TERCERA FASE DE 2 UNIDADES DE DOSIS DIARIAS DE 1MG DE VALERATO DE ESTRADIOL; Y D) UNA CUARTA FASE DE 2 UNIDADES DE DOSIS DIARIAS DE PLACEBO. DICHA ADMINISTRACION ES UTIL EN EL TRATAMIENTO DE HEMORRAGIA UTERINA DISFUNCIONAL Y EN LA ANTICONCEPCION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05022324A EP1787649B1 (de) | 2005-10-13 | 2005-10-13 | Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20070555A1 true PE20070555A1 (es) | 2007-07-12 |
Family
ID=35811580
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006001241A PE20070555A1 (es) | 2005-10-13 | 2006-10-12 | Uso de valerato de estradiol en combinacion con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral |
| PE2009001256A PE20100090A1 (es) | 2005-10-13 | 2006-10-12 | Preparado combinado polifasico comprendiendo estradiol y dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2009001256A PE20100090A1 (es) | 2005-10-13 | 2006-10-12 | Preparado combinado polifasico comprendiendo estradiol y dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral |
Country Status (22)
| Country | Link |
|---|---|
| EP (2) | EP1787649B1 (es) |
| JP (2) | JP5735200B2 (es) |
| KR (2) | KR20080065651A (es) |
| CN (1) | CN101312733A (es) |
| AR (1) | AR056694A1 (es) |
| AT (2) | ATE424828T1 (es) |
| CA (1) | CA2623024C (es) |
| CL (1) | CL2011000283A1 (es) |
| CY (2) | CY1110321T1 (es) |
| DE (2) | DE502005006837D1 (es) |
| DK (2) | DK1787649T3 (es) |
| DO (1) | DOP2006000221A (es) |
| ES (2) | ES2322479T3 (es) |
| HR (1) | HRP20090256T1 (es) |
| ME (1) | ME01056B (es) |
| PE (2) | PE20070555A1 (es) |
| PL (2) | PL1787649T3 (es) |
| PT (2) | PT1787649E (es) |
| SI (2) | SI1787649T1 (es) |
| TW (2) | TWI328453B (es) |
| UY (1) | UY29861A1 (es) |
| WO (1) | WO2007042296A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| EP1787649B1 (de) * | 2005-10-13 | 2009-03-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption |
| US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
| DE19540253C2 (de) * | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene |
| WO1998004265A1 (en) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |
| US6251956B1 (en) | 1998-08-20 | 2001-06-26 | Ortho Pharmaceutical Corporation | Combination progestin oral contraceptive regimen |
| EP1462106A1 (en) * | 2003-03-28 | 2004-09-29 | Pantarhei Bioscience B.V. | Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders |
| DE102004019743B4 (de) * | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| EP1787649B1 (de) * | 2005-10-13 | 2009-03-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat in Kombination mit Dienogest zur oralen Therapie der dysfunktionellen uterinen Blutung in Einheit mit einer oralen Kontrazeption |
-
2005
- 2005-10-13 EP EP05022324A patent/EP1787649B1/de not_active Revoked
- 2005-10-13 AT AT05022324T patent/ATE424828T1/de active
- 2005-10-13 DK DK05022324T patent/DK1787649T3/da active
- 2005-10-13 PT PT05022324T patent/PT1787649E/pt unknown
- 2005-10-13 ME MEP-2009-171A patent/ME01056B/me unknown
- 2005-10-13 DE DE502005006837T patent/DE502005006837D1/de not_active Expired - Lifetime
- 2005-10-13 PL PL05022324T patent/PL1787649T3/pl unknown
- 2005-10-13 SI SI200530672T patent/SI1787649T1/sl unknown
- 2005-10-13 ES ES05022324T patent/ES2322479T3/es not_active Expired - Lifetime
-
2006
- 2006-10-12 SI SI200630991T patent/SI1933843T1/sl unknown
- 2006-10-12 CN CNA2006800381810A patent/CN101312733A/zh active Pending
- 2006-10-12 AT AT06806225T patent/ATE497387T1/de active
- 2006-10-12 CA CA2623024A patent/CA2623024C/en active Active
- 2006-10-12 TW TW095137564A patent/TWI328453B/zh active
- 2006-10-12 DE DE502006008853T patent/DE502006008853D1/de active Active
- 2006-10-12 EP EP06806225A patent/EP1933843B1/de active Active
- 2006-10-12 JP JP2008534936A patent/JP5735200B2/ja active Active
- 2006-10-12 PE PE2006001241A patent/PE20070555A1/es not_active Application Discontinuation
- 2006-10-12 PL PL06806225T patent/PL1933843T3/pl unknown
- 2006-10-12 KR KR1020087011203A patent/KR20080065651A/ko not_active Ceased
- 2006-10-12 DK DK06806225.6T patent/DK1933843T3/da active
- 2006-10-12 KR KR1020107014574A patent/KR101218872B1/ko active Active
- 2006-10-12 PE PE2009001256A patent/PE20100090A1/es not_active Application Discontinuation
- 2006-10-12 PT PT06806225T patent/PT1933843E/pt unknown
- 2006-10-12 WO PCT/EP2006/009867 patent/WO2007042296A1/de not_active Ceased
- 2006-10-12 ES ES06806225T patent/ES2360302T3/es active Active
- 2006-10-13 AR ARP060104489A patent/AR056694A1/es not_active Application Discontinuation
- 2006-10-13 DO DO2006000221A patent/DOP2006000221A/es unknown
- 2006-10-13 UY UY29861A patent/UY29861A1/es not_active Application Discontinuation
-
2007
- 2007-01-09 TW TW096100872A patent/TW200829255A/zh unknown
-
2009
- 2009-05-05 HR HR20090256T patent/HRP20090256T1/xx unknown
- 2009-06-11 CY CY20091100621T patent/CY1110321T1/el unknown
-
2011
- 2011-02-10 CL CL2011000283A patent/CL2011000283A1/es unknown
- 2011-05-02 CY CY20111100422T patent/CY1111406T1/el unknown
-
2012
- 2012-11-19 JP JP2012253067A patent/JP2013047269A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9712523A (pt) | Novos derivados de pirazol heterociclilmetil-substituìdos | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| CL2009001899A1 (es) | Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01). | |
| PE20060485A1 (es) | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits | |
| CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
| UY31403A1 (es) | "derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos". | |
| AR084229A2 (es) | Preparado polifasico para la contracepcion a base de un estrogeno natural | |
| AR061959A1 (es) | Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas | |
| PE20070555A1 (es) | Uso de valerato de estradiol en combinacion con dienogest para la terapia oral de la hemorragia uterina disfuncional unida con una anticoncepcion oral | |
| NO20072893L (no) | Fast, peroralt prevensjonsmiddel | |
| BR0107881A (pt) | Uso de fsh tratamento de infertilidade | |
| MX2009008813A (es) | Composicion farmaceutica que contiene floroglucinol y paracetamol. | |
| NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
| CY1112775T1 (el) | Χρηση βαλεριανικης οιστραδιολης σε συνδυασμο με dienogest για την απο του στοματος θεραπεια της δυσλειτουργικης αιμορραγιας της μητρας σε ενοτητα με αντισυλληψη απο του στοματος | |
| CL2011000252A1 (es) | Uso de estriol para preparar un medicamento util en la prevencion y/o el tratamiento de atrofia urogenital en mujeres. | |
| UY29379A1 (es) | Forma farmacéutica peroral salida para la anticoncepción | |
| UY26966A1 (es) | Uso de antiprogestinas para la inducción de apoptosis en una célula | |
| PE20070769A1 (es) | Procedimiento para la produccion de una preparacion farmaceutica monofasica para la terapia oral de la hemorragia uterina disfuncional | |
| PE20000887A1 (es) | Equipo anticonceptivo de tipo "solo progestageno" que permite un buen control del ciclo | |
| AR049195A1 (es) | Uso de una combinacion de etinilestradiol y acetato de clormadinona para la preparacion de un medicamento | |
| AR049220A1 (es) | Uso de 7-ter-butoxiiminometilcamptotecina en la preparacion de un medicamento util para el tratamiento de neoplasmas uterinos | |
| DE602006018471D1 (de) | 17-alpha-substituierte derivate von östradiol mit wundheilender wirkung | |
| PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa | |
| CU20090062A7 (es) | Uso de valerato de estradiol o 17beta-estradiol en combinación con dienogest en una terapia oral para mantener y/o incrementar la líbido femenina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |